Valuation (7%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 167.80 | -15.38 |
PEG Ratio (TTM) | -17.26 | -0.63 |
P/S Ratio (TTM) | 3.41 | 1.10 |
P/B Ratio (TTM) | 11.21 | 2.68 |
P/FCF Ratio (TTM) | 96.75 | 11.61 |
Price to 5YR AVG Earnings Ratio | N/A | 5.95 |
Price to 5YR AVG FCF Ratio | N/A | 7.68 |
Profitability (30%) |
Company | Industry |
---|---|---|
ROA (TTM) | 0.98% | 0.60% |
ROE (TTM) | 10.92% | 8.83% |
Net Profit Margin (TTM) | 2.00% | 6.10% |
ROIC 5YR AVG | N/A | 4.76% |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -9.99% | N/A | N/A |
Revenue | 11.77% | N/A | N/A |
Net Income | -11.39% | N/A | N/A |
Cash Flow | 70.51% | N/A | N/A |
Health (49%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.71 | 0.42 |
Quick Ratio (TTM) | 1.71 | -1.10 |
D/E Ratio (TTM) | 1.06 | 3.50 |
Interest Coverage (TTM) | 3.31 | 3.18 |
Piotroski F-Score | 5 | 5 |
Altman Z-Score | 2.35 | 1.43 |
LTL to 5YR AVG FCF | N/A | 25.29 |
Shares Outstanding Growth 5YR AVG | N/A | -7.53% |